Akoustis Technologies Inc expected to post a loss of 18 cents a share - Earnings Preview

Aktis Oncology

09/02/2024 15:48

* Akoustis Technologies Inc  AKTS.OQ   AKTS.O  is expected
to show
a rise in quarterly revenue when it reports  results on February
13 for the period ending December 31 2023
    * The Huntersville North Carolina-based  company is expected
to
report a 19.2% increase in revenue to $6.988 million from $5.87
million a year ago, according to the mean estimate from 5
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Akoustis Technologies
Inc is
for a loss of 18 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Akoustis
Technologies Inc is $1.00​, above​ its last closing price
of $0.66. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.18       -0.18      -0.26     Missed  -44.4
 Jun. 30 2023  -0.16       -0.17      -0.21     Missed  -26.5
 Mar. 31 2023  -0.20       -0.19      -0.20     Missed  -4.2​
 Dec. 31 2022  -0.25       -0.25      -0.19     Beat    24
 ​​Sep.        -0.22       -0.20      -0.28     Missed  -38.3
 30 2022                                                
 Jun. 30 2022              -0.19      -0.26     Missed  -34.5​
 Mar. 31 2022  -0.23       -0.22      -0.22     Met     0
 Dec. 31 2021  -0.22       -0.20      -0.23     Missed  -12.2
 This summary was machine generated February 9 at 15:48 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)